Tag: Hepatitis
Integration of Opioid, Infectious Disease Treatment Needed
Expert panel recommends five action steps for treating opioid abuse and its intersecting epidemics
Good Outcomes for HCV-Negative Recipients of HCV Kidneys
All 20 recipients experienced HCV cure, good quality of life, excellent renal function
July 28 Is World Hepatitis Day
The awareness day promotes the need to scale up testing, treatment activities
NFID Initiative Working to Up Hepatitis B Vaccination Rates
National Foundation for Infectious Diseases working to increase screening, vaccination in those at risk
WHO Targets for Chronic Hepatitis B Will Be Cost-Effective
Achieving WHO targets for diagnosis, treatment by 2030 will be cost-effective at $103 per QALY
Canada Updates Guidelines for Hepatitis C Virus Infection
Recommendations include screening for all born from 1945 to 1975, all-oral treatment regimens
One-Third of Hep C Rx Receive Absolute Denial From Insurers
Both private and public insurers continue to deny coverage for drugs at high rates
Availability of Generic Antivirals for Hepatitis B Increasing
Drop in median price of WHO-prequalified generic tenofovir from $208 to $32 from 2004 to 2016
Universal Screening Best Strategy for Hepatitis C in France
Universal screening is cost-effective when treatment is initiated regardless of fibrosis stage
HCV-Infected Kidney Transplant More Efficient in HCV-Infected
Increases quality-adjusted life expectancy, reduces costs versus transplant of HCV-uninfected kidney
